Cancer

Updated HPV vaccine recommendations endorsed

As national vaccination rates for the human papillomavirus (HPV) remain low, The University of Texas MD Anderson Cancer Center has again united with the 68 other National Cancer Institute (NCI)-designated cancer centers in ...

Jan 11, 2017
popularity11 comments 0

Successful phase 3 trial of drug for liver cancer

An international phase 3 trial has found that the drug regorafenib improved survival in patients with advanced hepatocellular carcinoma (HCC), a form of liver cancer, giving people who previously had no other options a better ...

Jan 18, 2017
popularity121 comments 0